학술논문

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 11 May 2021, 5(9):2438-2448)
Subject
Language
English
ISSN
24739537
24739529